>
Surgical Innovations logo

SUN - Surgical Innovations Share Price

3.35p 0.1  3.1%

Last Trade - 14/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £31.2m
Enterprise Value £29.2m
Revenue £6.33m
Position in Universe 1377th / 1826
Bullish
Bearish
Unlock SUN Revenue
Momentum
Relative Strength (%)
1m -3.74%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.21%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
5.47 6.09 8.75 11.0 10.7 6.33 12.8 6.10 +3.0%
-34.5 -7.4
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, SurgicalInnovations Group Plc revenues decreased 41% to £6.3M. Netloss increased 25% to £3.3M. Revenues reflect SI Brandsegment decrease of 42% to £3.4M, OEM segment decrease of66% to £608K, Distribution segment decrease of 25% to £2.3M, United Kingdom segment decrease of 41% to £3.7M, USsegment decrease of 52% to £1M, Europe segment decrease of43% to £726K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SUN
Graphical History

Revenue

SUN Revenue Unlock SUN Revenue

Net Income

SUN Net Income Unlock SUN Revenue

Normalised EPS

SUN Normalised EPS Unlock SUN Revenue

PE Ratio Range

SUN PE Ratio Range Unlock SUN Revenue

Dividend Yield Range

SUN Dividend Yield Range Unlock SUN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SUN EPS Forecasts Unlock SUN Revenue
Profile Summary

Surgical Innovations Group plc is a United Kingdom-based holding company, which is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (SI) and precision engineering (PE) markets. The Company sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The Company operates through three segments: SI Brand, OEM and PE. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The PE segment is engaged in the research, development, manufacture and sale of minimally invasive technology products for PE applications.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated September 20, 1988
Public Since July 7, 1998
No. of Shareholders: n/a
No. of Employees: 83
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 932,816,177
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SUN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SUN
Upcoming Events for SUN
Monday 6th September, 2021 Estimate
Half Year 2021 Surgical Innovations Group PLC Earnings Release
Friday 17th September, 2021 Estimate
Surgical Innovations Group PLC Annual Shareholders Meeting
Frequently Asked Questions for Surgical Innovations
What is the Surgical Innovations share price?

As of 14/05/21, shares in Surgical Innovations are trading at 3.35p, giving the company a market capitalisation of £31.2m. This share price information is delayed by 15 minutes.

How has the Surgical Innovations share price performed this year?

Shares in Surgical Innovations are currently trading at 3.35p and the price has moved by 0.106k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Surgical Innovations price has moved by 65.74% over the past year.

What are the analyst and broker recommendations for Surgical Innovations?

Of the analysts with advisory recommendations for Surgical Innovations, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Surgical Innovations is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Surgical Innovations next release its financial results?

Surgical Innovations is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Surgical Innovations dividend yield?

Surgical Innovations does not currently pay a dividend.

Does Surgical Innovations pay a dividend?

Surgical Innovations does not currently pay a dividend.

When does Surgical Innovations next pay dividends?

Surgical Innovations does not currently pay a dividend.

How do I buy Surgical Innovations shares?

To buy shares in Surgical Innovations you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Surgical Innovations?

Shares in Surgical Innovations are currently trading at 3.35p, giving the company a market capitalisation of £31.2m.

Where are Surgical Innovations shares listed? Where are Surgical Innovations shares listed?

Here are the trading details for Surgical Innovations:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: SUN
What kind of share is Surgical Innovations?

Based on an overall assessment of its quality, value and momentum, Surgical Innovations is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Surgical Innovations share price forecast 2021?

Shares in Surgical Innovations are currently priced at 3.35p. At that level they are trading at 49.25% discount to the analyst consensus target price of 6.60.

Analysts covering Surgical Innovations currently have a consensus Earnings Per Share (EPS) forecast of 0.001 for the next financial year.

How can I tell whether the Surgical Innovations share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgical Innovations. Over the past six months, the relative strength of its shares against the market has been 0.118k%. At the current price of 3.35p, shares in Surgical Innovations are trading at 62.86% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Surgical Innovations PE Ratio?

We were not able to find PE ratio data for Surgical Innovations.

Who are the key directors of Surgical Innovations?

Surgical Innovations's management team is headed by:

Douglas Liversidge - NED
Michael McMahon - NED
Chris Rea - NED
Nigel Rogers - NEC
David Marsh - CEO
Adam Power - NED
Alex Hogg - OTH
Who are the major shareholders of Surgical Innovations?

Here are the top five shareholders of Surgical Innovations based on the size of their shareholding:

Getz Bros & Co Zug Inc Corporation
Percentage owned: 11.69% (109.1m shares)
HealthInvest Small & MicroCap Fund Mutual Fund
Percentage owned: 7.53% (70.3m shares)
Healthinvest Partners AB Investment Advisor/Hedge Fund
Percentage owned: 7.45% (69.5m shares)
Business Growth Fund Limited Private Equity
Percentage owned: 6.46% (60.3m shares)
Ruffer LLP Investment Advisor/Hedge Fund
Percentage owned: 6.43% (60.0m shares)
Similar to SUN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.